About MET
|
|
With the development of globalization, the demand for international assistance, medical tourism, medical technology and industrial export and exchange among countries is on the rise. The level and quality of medical care in Taiwan have always been a pride for Taiwanese, and the level of medical service technology is among the leading positions in Asia. Taiwan’s medical care not only has huge potential output value but also has great international competitiveness. As early as 60 years ago, based on the humanitarian aid concept of “medical treatment without national boundaries, service without borders,” Taiwan promoted diplomatic medical aid based on friendship. With the change of the international situation, Taiwan’s medical diplomacy strategy has changed from simple medical assistance to diversified medical industry chain cooperation. This approach not only to assists in the local development of medical care, but also combines Taiwan’s medical-related industries to drive technical and market exchanges between both sides. In the past 20 years, through sub-projects such as “Overseas Medical Talent Training,” “International Medical Treatment,” “Medical Industry Export,” and “Overseas Medical and Health Layout,” the footprint of Taiwan’s medical industry has spread to every corner of the world. The overall international development of the medical and health industry has become Taiwan’s goal to strengthen diplomatic status and upgrade industrial value.
Especially since 2016, the Taiwan government has actively promoted the “New Southbound Policy” and the “Five Plus Two Industry Innovation Plan,” both of which are conducive to the upgrading and external development of the medical industry. In addition, the Ministry of Health and Welfare has invested in the “International Health Industry Layout” and the “Medium and Long-Term Plan for New Southbound Medical and Health Cooperation and Industrial Chain Development,” and the core concept of “High Quality, Medium Price,” established an overall marketing channel in the international target market. This is to further promote medical service brands with Taiwanese characteristics and improve inbound international medical services, advance into the medical and health industry market of “New Southbound” nations, establish the characteristic services and development advantages of Taiwan’s medical industry, formulate the development opportunities and successful model strategies of Taiwan’s industry, seek opportunities to enter the New Southbound market, and enhance outbound Taiwan medical and health strength output.
In order to promote the internationalization and industrialization of Taiwan’s medical and health industry, the industry, government and academic circles have jointly organized “Medical Excellence TAIWAN (MET), a consortium as legal person.” In the future, under the guidance of the government department, MET will assist in gathering medical institutions and the health care industry, to build a resource network platform and bring an integration effect.
Especially since 2016, the Taiwan government has actively promoted the “New Southbound Policy” and the “Five Plus Two Industry Innovation Plan,” both of which are conducive to the upgrading and external development of the medical industry. In addition, the Ministry of Health and Welfare has invested in the “International Health Industry Layout” and the “Medium and Long-Term Plan for New Southbound Medical and Health Cooperation and Industrial Chain Development,” and the core concept of “High Quality, Medium Price,” established an overall marketing channel in the international target market. This is to further promote medical service brands with Taiwanese characteristics and improve inbound international medical services, advance into the medical and health industry market of “New Southbound” nations, establish the characteristic services and development advantages of Taiwan’s medical industry, formulate the development opportunities and successful model strategies of Taiwan’s industry, seek opportunities to enter the New Southbound market, and enhance outbound Taiwan medical and health strength output.
In order to promote the internationalization and industrialization of Taiwan’s medical and health industry, the industry, government and academic circles have jointly organized “Medical Excellence TAIWAN (MET), a consortium as legal person.” In the future, under the guidance of the government department, MET will assist in gathering medical institutions and the health care industry, to build a resource network platform and bring an integration effect.
MET Organizational Structure
|
MET has a total of 25 directors on the board of directors, including one chairman, two vice-chairmen, and five supervisors. It also employs experts from medical institutions, medical materials, biotechnology and Pharma, smart medical and other related health industries to form a consulting team.
To execute MET’s business, one chief executive director and three deputy executive directors will be appointed to be responsible for carrying out the actual business under the direction of the chairman. |
|
Board of Directors
Yu-Ray Chen
Chairman
Chairman
- Honorary chairman, chang gung steering commottee
- Director, Chang Gung Medical Foundation Board of Directors
- Director, Noordhoff Craniofacial Foundation
- Member of Editorial Board, The Journal of Craniofacial Surgery
Eric K. Chen Vice Chairman
|
Pi-Sheng Wang Vice Chairman
|
Hung-Yi Chiou Director Investigator and Director Institute of Population Health Sciences, National Health Research Institutes Distinguished |
James C.F Huang Director Chairman, TAITRA |
Simon Erh-Hui Tsai Director Adviser, Executive Yuan of Taiwan |
Shu-Lung Wang Director PRESIDENT, Fomed Biotech Inc. |
Chiang-Liang Wu Director Managing director and Chairman, Taiwan Region Hospital Association |
Fei-Peng Lee Director President, Taiwan Nongovernmental Hospitals and Clinics Association |
Te-Tsun Shen Director Deputy Executive Director, Steering Committee of E-Da Healthcare Group |
Der -Yang Cho Director SUPERINTENDENT, China Medical University Hospital |
Shinn-Zong Lin Director Superintendent, Hualien Tzu Chi Hospital |
Jeng-Fong Chiou Director Superintendent ,Taipei Medical University Hospital |
Ta-Chuan Hung Director Vice superintendent, MacKay Memorial Hospital, Taipei, Taiwan. |
Alex Hung Director ADMINISTRATIVE DEPUTY SUPERINTENDENT, Shin Kong Wu Ho-Su Memorial Hospital |
Amy Hsu Director PRESIDENT, Ten-ChEn General Hospital |
Yen-Chou Chang Director tainan dental association 名譽理事長 |
Wei-Jen Chang Director Professor,Taipei Medical University President, Taiwan Association for the Promotion of Oral Biotechnology and Medical Devices |
Min-Che Tung Director SUPERINTENDENT, Tungs' Taichung MetroHarbor Hospital |
Janet Huang Director CEO, Show Chwan Health Care System |
Tong-Young Lee Director
|
Inn-Wen Chong Director Superintendent, Kaohsiung Medical University Chung-Ho Memorial Hospital |
Chih-Cheng Chien Director Vice Superintendent, Cathay General Hospital |
Liang-Lung Su Director Tung Sheng Dental Supply Co.,Ltd. |
Huei-Cheng Sue Director Vice Chief Executive Officer, Chang Gung Memorial Hospital |
Supervisor
Michel Ching-Long LU Former Ambassador, France and Haiti |
Fang-Hsin Lee President, Y.S.P. Southeast Asia Holding Bhd. |
Ming-Feng Hou PROFESSOR, Kaohsiung Medical University Chung-Ho Memorial Hospital |
Peter Tsai chairman, Orient EuroPharma (OEP) |
Chia-Jui Su M.D./Esq., KPMG in taiwan |
Advisor
NUMATA Mikio FORMER Chief Representative, Japan-Taiwan Exchange Association |
Shou-Jen Kuo Former Superintendent, Changhua Christian Healthcare System |
Samuel Wang 衛生福利部新南向諮議會委員 |
Chun-Pin Lin Distinguished Professor, NTU |
Shih-Chia Lin
|
Chiao-Chang Huang
|
Yuh-Jyh Jong Chair Professor, Graduate Institute of Clinical Medicine, Kaohsiung Medical University |
按一下這裡來編輯。
Ming-Yen Wu CEO
|
Carlos Hsu Vice CEO CEO, Chang Gung medical foundation |